EUVIMEDEUVIMED entdecken
Crossref

Comparative Analysis of SARIMA and Neural Network Model Performance in Forecasting AstraZeneca and Moderna Stock Trading Volume Post-COVID-19 Pandemic

Sayida Nafisa, Debrina Zarqa Dermawan, Risma Nurhalisa, Aqilla Rahmi

International Journal of Business Forecasting and Marketing Intelligence · 2026 · 1 (1)

DOI: 10.1504/ijbfmi.2026.10077925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Business Forecasting and Marketing Intelligence, 2026. Verfasst von Sayida Nafisa und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Nafisa, S., Dermawan, D. Z., Nurhalisa, R., & Rahmi, A. (2026). Comparative Analysis of SARIMA and Neural Network Model Performance in Forecasting AstraZeneca and Moderna Stock Trading Volume Post-COVID-19 Pandemic. International Journal of Business Forecasting and Marketing Intelligence, 1(1). https://doi.org/10.1504/ijbfmi.2026.10077925

Vancouver

Nafisa S, Dermawan DZ, Nurhalisa R, Rahmi A. Comparative Analysis of SARIMA and Neural Network Model Performance in Forecasting AstraZeneca and Moderna Stock Trading Volume Post-COVID-19 Pandemic. International Journal of Business Forecasting and Marketing Intelligence. 2026;1(1). doi:10.1504/ijbfmi.2026.10077925

BibTeX
@article{Nafisa2026,
  author = {Nafisa, Sayida and Dermawan, Debrina Zarqa and Nurhalisa, Risma and Rahmi, Aqilla},
  title = {Comparative Analysis of SARIMA and Neural Network Model Performance in Forecasting AstraZeneca and Moderna Stock Trading Volume Post-COVID-19 Pandemic},
  journal = {International Journal of Business Forecasting and Marketing Intelligence},
  year = {2026},
  volume = {1},
  number = {1},
  doi = {10.1504/ijbfmi.2026.10077925}
}
Kostenlos starten →